/Walgreens%20Boots%20Alliance%20Inc%20store-%20by%20Sundry%20Photography%20via%20Shutterstock.jpg)
With a market cap of $10.1 billion, Walgreens Boots Alliance, Inc. (WBA) is a global healthcare, pharmacy, and retail company operating in the United States and internationally. The company provides a broad range of services through its U.S. Retail Pharmacy, International, and U.S. Healthcare segments, including prescription and non-prescription drugs, health and wellness products, and value-based medical care.
Analysts expect the Deerfield, Illinois-based company to report adjusted earnings of $0.25 per share in Q4 2025, down 35.9% from $0.39 per share in the year-ago quarter. However, the company has surpassed Wall Street's earnings estimates in the last four quarters.
For fiscal 2025, analysts expect the largest U.S. drugstore chain to report an adjusted EPS of $1.70, a decrease of nearly 41% from $2.88 in fiscal 2024.
Shares of Walgreens Boots Alliance have dropped 2.6% over the past 52 weeks, lagging behind both the S&P 500 Index's ($SPX) 16.8% return and the Consumer Staples Select Sector SPDR Fund’s (XLP) 3.6% gain over the same period.
Shares of Walgreens Boots Alliance recovered marginally following its Q3 2025 results on Jun. 26 due to better-than-expected adjusted EPS of $0.38 and revenue of around $39 billion, driven by aggressive cost-cutting measures, including executive reductions and store closures. Key contributors included an 8% rise in U.S. retail pharmacy sales to $30.7 billion and a 10.3% increase in same-store sales, reflecting the management’s $1 billion cost-reduction plan and strategic store closures.
Analysts' consensus view on WBA stock is cautious, with a "Hold" rating overall. Among 13 analysts covering the stock, one recommends "Strong Buy," 11 suggest "Hold," and one advises "Moderate Sell." As of writing, the stock is trading above the average analyst price target of $11.54.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
